EPTIS
BAM Logo

HER2 BRISH Breast Diagnostic

EPTIS factsheet 585752 | Last revision 2019-06-11 | URL: https://www.eptis.bam.de/pts585752 https://www.eptis.bam.de/pts585752

PT provider
PT provider RCPAQAP RCPAQAP
Based in Australia
Language(s) English
Remarks
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Single probe or dual probe HER2 BRISH for breast cancer interpretation Stained sections of H&E, HER2 IHC & HER2 BRISH slides are provided as virtual micropscope slide images for -
-
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Yes
Regularly operated Yes (6 cases per survey/2 surveys per year)
Year of first operation
Contact details of the PT provider
Provider Contact person
RCPAQAP
Suite 201/8 Herbert Street
St Leonards, 2065
Australia

Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Web: https://www.rcpaqap.com.au/ https://www.rcpaqap.com.au/
Megan Cooke
Phone: (61 2) 9045 6012
Fax: (61 2) 9356 2003
Email: megan.cooke@rcpaqap.com.au megan.cooke@rcpaqap.com.au
If you find any mistakes please contact the responsible EPTIS coordinator in Australia, Ms Luminata Antin. Ms Luminata Antin.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21